Guangdong Jiaying Pharmaceutical Co Ltd
002198
Company Profile
Business description
Guangdong Jiaying Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is mainly engaged in the research and development, production, and sales of pharmaceuticals. The company's main products cover throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal. Its product portfolio consists of Shuangliao Houfeng San, Chongganling Tablets, Jiegu Qili Tablets (Capsules), Shufeng Huoluo Tablets, Tiaojing Huoxue Tablets, etc.
Contact
Dongsheng Industrial Park
Zone B
Guangdong Province
Meizhou514021
CHNT: +86 7532321916
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
594
Stocks News & Analysis
stocks
ASX reporting season wrap: BHP, banks, CSL bloodbath and more
A round up of notable stories and reactions as ASX earnings season continues.
stocks
Stock showdown: How do ASX healthcare giants compare on key investing criteria?
Our healthcare analyst Shane Ponraj helps me compare the moatiness and growth prospects of two sector heavyweights.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,234.30 | 55.70 | -0.60% |
CAC 40 | 7,969.69 | 31.40 | 0.40% |
DAX 40 | 24,363.09 | 69.75 | 0.29% |
Dow JONES (US) | 45,631.74 | 846.24 | 1.89% |
FTSE 100 | 9,321.40 | 12.20 | 0.13% |
HKSE | 25,339.14 | 234.53 | 0.93% |
NASDAQ | 21,496.54 | 396.22 | 1.88% |
Nikkei 225 | 42,633.29 | 23.12 | 0.05% |
NZX 50 Index | 13,042.76 | 151.31 | -1.15% |
S&P 500 | 6,466.91 | 96.74 | 1.52% |
S&P/ASX 200 | 8,967.40 | 57.00 | -0.63% |
SSE Composite Index | 3,825.76 | 54.66 | 1.45% |